Items where authors include "Irvine, A.D."

Article

Cork, M.J. orcid.org/0000-0003-4428-2428, Deleuran, M., Geng, B. et al. (8 more authors) (2025) Long-term safety of abrocitinib in moderate-to-severe atopic dermatitis: integrated analysis by age. The Journal of Allergy and Clinical Immunology: In Practice. ISSN 2213-2198

Gribaleva, E. orcid.org/0000-0001-5693-8194, Chan, K., Chivardi Moreno, C. et al. (60 more authors) (2025) The UK-Irish Atopic eczema Systemic TherApy Register (A*STAR): baseline characteristics of the cohort. British Journal of Dermatology. ljaf039. ISSN 0007-0963

Alexander, H. orcid.org/0000-0002-0241-5408, Malek, R., Prieto-Merino, D. et al. (57 more authors) (2024) A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register. British Journal of Dermatology, 191 (6). pp. 988-999. ISSN 0007-0963

Guttman-Yassky, E., Esfandiari, E., Mano, H. et al. (6 more authors) (2024) Durable improvements in atopic dermatitis in the head and neck and across other anatomic regions with rocatinlimab. Archives of Dermatological Research, 316 (10). 747. ISSN 0340-3696

Bruce, G. orcid.org/0000-0003-4713-3647, Rosala-Hallas, A., Jones, A.P. et al. (28 more authors) (2024) The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children – results from the TREAT trial. British Journal of Dermatology, 191 (5). pp. 851-852. ISSN 0007-0963

Flohr, C. orcid.org/0000-0003-4884-6286, Rosala-Hallas, A., Jones, A.P. et al. (76 more authors) (2023) Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial. British Journal of Dermatology, 189 (6). pp. 674-684. ISSN 0007-0963

Flohr, C. orcid.org/0000-0003-4884-6286, Irvine, A.D. orcid.org/0000-0002-9048-2044, Cork, M.J. orcid.org/0000-0003-4428-2428 et al. (6 more authors) (2023) Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis. British Journal of Dermatology, 189 (2). pp. 238-240. ISSN 0007-0963

Bieber, T. orcid.org/0000-0002-8800-3817, Thyssen, J.P. orcid.org/0000-0003-3770-1743, Irvine, A.D. orcid.org/0000-0002-9048-2044 et al. (6 more authors) (2023) Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis. Clinical and Experimental Dermatology, 48 (8). pp. 881-888. ISSN 0307-6938

Leshem, Y.A., Bissonnette, R., Paul, C. et al. (5 more authors) (2019) Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statement. Journal of the European Academy of Dermatology and Venereology, 33 (5). pp. 807-815. ISSN 0926-9959

Simpson, E.L., Reynolds, N.J., Flohr, C. et al. (5 more authors) (2018) Response to "Comment on: 'When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council'''. Journal of The American Academy of Dermatology, 79 (2). E25-E26. ISSN 0190-9622

Simpson, E.L., Bruin-Weller, M., Flohr, C. et al. (26 more authors) (2017) When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council. Journal of The American Academy of Dermatology, 77 (4). pp. 623-633. ISSN 0190-9622

Tsoi, L.C., Spain, S.L., Knight, J. et al. (199 more authors) (2012) Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nature Genetics, 44 (12). pp. 1341-1348. ISSN 1061-4036